TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
+13.26%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$3.71B
AUM Growth
+$351M
(+10%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
21.85%
Holding
5,705
New
583
Increased
2,927
Reduced
1,693
Closed
465
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$138M |
| 2 |
Palantir
PLTR
|
+$21.2M |
| 3 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$20M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$18.1M |
| 5 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$17.4M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$229M |
| 2 |
Meta Platforms (Facebook)
META
|
+$44.8M |
| 3 |
Broadcom
AVGO
|
+$44.2M |
| 4 |
Amazon
AMZN
|
+$39.4M |
| 5 |
Microsoft
MSFT
|
+$34.1M |
Sector Composition
| 1 | Technology | 20.51% |
| 2 | Financials | 11.6% |
| 3 | Healthcare | 8.36% |
| 4 | Industrials | 6.7% |
| 5 | Consumer Discretionary | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Frontline
FRO
$5.17B
| $24.1K | ﹤0.01% |
1,470
-78,084
| -98% | -$1.28M |
|
|
MBX
3577
MBX Biosciences
MBX
$336M
| $24.1K | ﹤0.01% |
2,110
+745
| +55% | +$8.5K |
|
|
RAPP
3578
Rapport Therapeutics
RAPP
$1.22B
| $23.9K | ﹤0.01% |
2,100
+1,178
| +128% | +$13.4K |
|
3579
Precigen
PGEN
$1.32B
| $23.9K | ﹤0.01% |
16,814
+9,378
| +126% | +$13.3K |
|
3580
8x8 Inc
EGHT
$289M
| $23.8K | ﹤0.01% |
12,168
+5,146
| +73% | +$10.1K |
|
3581
Inovio Pharmaceuticals
INO
$123M
| $23.8K | ﹤0.01% |
11,687
+6,073
| +108% | +$12.4K |
|
3582
Esperion Therapeutics
ESPR
$534M
| $23.8K | ﹤0.01% |
24,158
+19,951
| +474% | +$19.6K |
|
|
USAR
3583
USA Rare Earth Inc
USAR
$1.58B
| $23.8K | ﹤0.01% |
+2,168
| New | +$23.8K |
|
3584
Rimini Street
RMNI
$424M
| $23.7K | ﹤0.01% |
6,296
+3,339
| +113% | +$12.6K |
|
3585
Inspired Entertainment
INSE
$258M
| $23.7K | ﹤0.01% |
2,905
+1,844
| +174% | +$15.1K |
|
3586
Lufax Holding
LU
$2.88B
| $23.7K | ﹤0.01% |
8,477
+8,473
| +211,825% | +$23.6K |
|
|
KKR.PRD
3587
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$3.01B
| $23.6K | ﹤0.01% |
+440
| New | +$23.6K |
|
3588
Cassava Sciences
SAVA
$111M
| $23.6K | ﹤0.01% |
13,029
+6,467
| +99% | +$11.7K |
|
3589
Inogen
INGN
$234M
| $23.6K | ﹤0.01% |
3,351
+1,520
| +83% | +$10.7K |
|
|
SEPN
3590
Septerna Inc
SEPN
$700M
| $23.5K | ﹤0.01% |
2,225
+437
| +24% | +$4.62K |
|
3591
Bioceres Crop Solutions
BIOX
$101M
| $23.5K | ﹤0.01% |
+5,256
| New | +$23.5K |
|
3592
OneWater Marine
ONEW
$255M
| $23.5K | ﹤0.01% |
1,754
+1,255
| +252% | +$16.8K |
|
3593
Strawberry Fields REIT
STRW
$159M
| $23.5K | ﹤0.01% |
2,227
+632
| +40% | +$6.66K |
|
3594
Vanguard FTSE Developed Markets ETF
VEA
$175B
| $23.1K | ﹤0.01% |
406
-7,640
| -95% | -$436K |
|
3595
Zura Bio
ZURA
$130M
| $23.1K | ﹤0.01% |
22,029
+14,181
| +181% | +$14.9K |
|
3596
MBIA
MBI
$394M
| $23.1K | ﹤0.01% |
5,327
+1,925
| +57% | +$8.35K |
|
3597
AirSculpt Technologies
AIRS
$408M
| $23.1K | ﹤0.01% |
4,785
+760
| +19% | +$3.67K |
|
3598
KRONOS Worldwide
KRO
$688M
| $23K | ﹤0.01% |
3,713
+1,028
| +38% | +$6.37K |
|
3599
Lifecore Biomedical
LFCR
$294M
| $23K | ﹤0.01% |
2,832
+1,019
| +56% | +$8.27K |
|
|
BTX
3600
BlackRock Technology and Private Equity Term Trust
BTX
$815M
| $22.9K | ﹤0.01% |
3,122
-924
| -23% | -$6.78K |
|